vTv Therapeutics Inc. (VTVT) Institutional Ownership

Ownership Summary

vTv Therapeutics Inc. (NASDAQ:VTVT) is held by 35 institutional investors per 13F filings through March 2026.

• These investors collectively held 12.0% of vTv Therapeutics's outstanding shares in March 2026, down from 15.3% in December 2025.
• Their total shares held in VTVT increased 23.5% from the prior quarter, while the number of investors in vTv Therapeutics increased 59.09% year over year.
• During the quarter, 19 of these 35 funds increased positions in VTVT, 4 reduced exposure, and 12 held steady.
• Combined, these investors held 1.49Mn shares in VTVT for March 2026, up by 283.04K shares quarter on quarter, and up 915.55K shares year over year.
• As of March 31, 2026, Samsara BioCapital, LLC held the largest stake in vTv Therapeutics with 298.5K shares, accounting for 2.41% of total shares outstanding.
• The most significant purchases of VTVT for the quarter ending March 2026 came from MILLENNIUM MANAGEMENT LLC (206.29K), VANGUARD CAPITAL MANAGEMENT LLC (108.92K), VANGUARD FIDUCIARY TRUST CO (16.13K), MARSHALL WACE, LLP (13.39K), State Street Corp (10.67K).
• Leading sellers of vTv Therapeutics shares for the quarter ending March 2026 were Trails Edge Capital Partners, LP (91.42K), FMR LLC (8.46K), 683 Capital Management, LLC (2.27K), OSAIC HOLDINGS, INC. (1).
• Per Business Quant, the top 10 investors in VTVT for the quarter ending March 2026 include Samsara BioCapital, LLC (298.5K), FMR LLC (260.39K), MILLENNIUM MANAGEMENT LLC (206.29K), Siren, L.L.C. (163.0K), BAKER BROS. ADVISORS LP (148.31K), Trails Edge Capital Partners, LP (139.58K), VANGUARD CAPITAL MANAGEMENT LLC (108.92K), GEODE CAPITAL MANAGEMENT, LLC (32.89K), Northern Trust Corp (18.05K), VANGUARD FIDUCIARY TRUST CO (16.13K).